TG4010

Showing 1 posts of 1 posts found.

Lung cancer vaccine poised to begin phase IIb/III trials

September 1, 2010
Research and Development NSCLC, TG4010, Transgene, cancer vaccine

French biotech firm Transgene has received positive scientific advice from the EMA for late stage trials of its new lung …

Latest content